On Sunday, September 29 at 5:50 pm EST, CEO Doug Drysdale will appear on Dr. Drew on FOX Business to talk about the breakthrough innovations Cybin is leading to revolutionize the treatment of mental health. #MentalHealthInnovation #Biotechnology #Neuropsychiatry

#Cybin’s Chief Medical Officer Amir Inamdar will participate in a panel on “Advancement in Psychedelic Therapies for Neuropsychiatry” at the TDCowen 4th Annual Novel Mechanisms in Neuropsychiatry Summit at 10 am ET on Thursday, Sep. 26, 2024. Webcast: loom.ly/LKhbO8k

Live now: Advancement in Psychedelic Therapies for Neuropsychiatry Panel at the TD Cowen 4th Annual Novel Mechanisms in Neuropsychiatry Summit, Thursday, Sep 26 · 10–11 AM. $ATAI $CYBN $GHRS wsw.com/webcast/cowen1…

Today, #Cybin CEO Doug Drysdale joins Brandon Li on the With Power Podcast to talk about what makes Cybin different, working with the #FDA, and lessons from building companies. 📺Watch: loom.ly/X-gk3PA 📻Listen: loom.ly/TAq9_iE

Culture eats strategy for breakfast. From the amazing Peter Drucker, of course. So obvious, but so overlooked.

Today, we approved a drug for oral use for the treatment of schizophrenia in adults. fda.gov/news-events/pr…

BREAKING (LATE) --> FDA approves $BMY schizophrenia drug that could alter how disorder is treated Karuna's KarXT is approved. Brand name: Cobenfy statnews.com/2024/09/26/fda…

FDA approves first schizophrenia drug with a new mechanism of action since the 1950s tinyurl.com/34ceshw4 Karuna/Bristol Myers Squibb’s KarXT (Cobenfy), which acts on M1/M4 muscarinic acetylcholine receptors, expands the treatment landscape beyond dopamine-targeted drugs

Great to see this. COBENFY represents the first new pharmacological approach to treat schizophrenia in decades, with a mechanism of action distinct from current therapies news.bms.com/news/corporate…

Tune in tonight at 550pm ET

"This is the biggest breakthrough in psychiatry in 40 years." Yesterday, Doug Drysdale made a guest appearance on Dr. Drew on FOX Business to talk about the breakthrough innovations Cybin is developing to revolutionize the treatment of mental health. Watch:

#Cybin is pleased to announce the appointment of Dr. Mirza Rahman as Senior Vice President, Patient Safety & Pharmacovigilance and Dr. Marcelo Gutierrez, Vice President, Clinical Pharmacology. Learn more: loom.ly/4r6Nng0

Looking forward to it, Robert

#Cybin CEO Doug Drysdale will participate in the Water Tower Research LLC Fireside Chat next Tuesday, October 8, 2024, at 3:00 p.m. ET. to discuss our lead development programs, upcoming clinical milestones, and what differentiates our approach from other neuropsychiatric developments.

During Depression Awareness Month, we at Cybin are focused on the potential of CYB003 to transform the treatment of major depressive disorder. Our dedication to innovative solutions is a beacon of hope for many. Join us in shining a light on mental health this October.

#Cybin CEO Doug Drysdale will participate in the Water Tower Research LLC Fireside Chat tomorrow, October 8, 2024, at 3:00 p.m. ET. to discuss our lead development programs, upcoming clinical milestones, and what differentiates our approach from other neuropsychiatric developments.

An entrepreneur that changed India ndtv.com/india-news/rat…

On #WorldMentalHealthDay, we reaffirm our commitment to revolutionizing mental healthcare. With innovative, science-driven therapies, we strive to make mental wellness accessible for all, providing hope for those battling depression, anxiety, and other mental health challenges.

Read Robert Sassoon's recap and transcript from his fireside chat with CybinInc CEO Doug Drysdale, covering $CYBN's lead developments, upcoming clinical milestones, differentiators, and lessons learned and applied from the FDA’s Lykos NDA rejection. watertowerresearch.com/doc?docID=MS_C…

It is easy to forget or overlook just how challenging it is for people to come out, to be their genuine selves among family, friends, and in the workplace. WE, the family, friends, and colleagues can play our part in making them feel safe, loved, and included. A small gesture